Literature DB >> 8516804

Selective intraportal hepatocyte transplantation in analbuminemic and Gunn rats.

M D Holzman1, J Rozga, D F Neuzil, D Griffin, A D Moscioni, A A Demetriou.   

Abstract

Although significant progress has been achieved in isolated hepatocyte transplantation, the optimal site of cell implantation has not yet been determined. We have developed a novel experimental method of intraportal hepatocyte transplantation that allows easy assessment of the morphology and function of transplanted hepatocytes. Donor hepatocytes were harvested from Sprague-Dawley rats by in situ EDTA/collagenase perfusion. Fifteen recipient Nagase analbuminemic rats (NAR) underwent cannulation of the gastroduodenal vein under ether anesthesia. Either the posterior or anterior liver lobes were selectively infused with cells by occluding the portal venous supply of the nontransplanted liver lobes. Normal donor hepatocytes (2 x 10(7)) suspended in normal saline were infused over 1 min (4 ml). Recipients were treated with cyclosporine for the duration of the experiment. Plasma albumin levels were determined by ELISA, before and at various intervals after transplantation. In NAR rats transplanted with normal hepatocytes, there was a significant (P < 0.003) and sustained (12 weeks) increase in plasma albumin levels. Control NAR rats transplanted with NAR hepatocytes (n = 8) showed no significant changes in plasma albumin levels. Similarly, normal Wistar hepatocytes were infused intraportally into the posterior lobes of Gunn rats (n = 4), which lack the ability to conjugate bilirubin. Pre- and posttransplantation bile was collected following bile duct cannulation. Bile analysis by HPLC, demonstrated a significant (P = 0.04) increase in the level of bilirubin conjugates following transplantation and a corresponding decrease in total serum bilirubin (P = 0.04). Our experimental data demonstrate that direct selective intraportal infusion of hepatocytes is an effective technique of hepatocyte transplantation in the rat.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8516804     DOI: 10.1097/00007890-199306000-00002

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Functional comparison of bone marrow-derived liver stem cells: selection strategy for cell-based therapy.

Authors:  Daniel Inderbitzin; Itzhak Avital; Beat Gloor; Adrian Keogh; Daniel Candinas
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.452

2.  Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers.

Authors:  Yoshitaka Wakizaka; Toshio Miki; Abdul S Rao; Xue Wang; April L Goller; Anthony J Demetris; John J Fung; Thomas E Starzl; Luis A Valdivia
Journal:  Xenotransplantation       Date:  1997-11-01       Impact factor: 3.907

Review 3.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.

Authors:  Philippe-A Lysy; Mustapha Najimi; Xavier Stephenne; Annick Bourgois; Francoise Smets; Etienne-M Sokal
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

4.  In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system--initial experience in mice.

Authors:  Alain Luciani; Alexandre Parouchev; Pierre Smirnov; Gustavo Braga; Claire Wilhelm; Florence Gazeau; Lyes Boudechiche; Aurore L'hermine-Coulomb; Ibrahim Dagher; Dominique Franco; Alain Rahmouni; Michèle Hadchouel; Anne Weber; Olivier Clement
Journal:  Eur Radiol       Date:  2007-10-05       Impact factor: 5.315

5.  Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease.

Authors:  Kristen J Skvorak; Harbhajan S Paul; Kenneth Dorko; Fabio Marongiu; Ewa Ellis; Donald Chace; Carolyn Ferguson; K Michael Gibson; Gregg E Homanics; Stephen C Strom
Journal:  Mol Ther       Date:  2009-05-12       Impact factor: 11.454

6.  Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat.

Authors:  M Muraca; C Ferraresso; M T Vilei; A Granato; M Quarta; E Cozzi; M Rugge; K A Pauwelyn; M Caruso; I Avital; D Inderbitzin; A A Demetriou; S J Forbes; G Realdi
Journal:  Gut       Date:  2007-07-19       Impact factor: 23.059

Review 7.  Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory.

Authors:  Henning C Fiegel; Peter M Kaufmann; Helge Bruns; Dietrich Kluth; Raymund E Horch; Joseph P Vacanti; Ulrich Kneser
Journal:  J Cell Mol Med       Date:  2007-11-16       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.